Securing a healthy future for Africa
The Biovac Institute (Biovac) is a Public Private Partnership between the South African government and the Biovac Consortium. The Biovac Institutes’ vision is to be a Centre of Excellence rooted in Africa for the development and manufacture of affordable quality vaccines for Africa and the developing world’s needs. Biovac’s focus is on ensuring that the country has the required domestic capacity to respond to both local and regional vaccine needs.
Biovac recognises the need for a domestic manufacturer of human vaccines to enable the Southern African region to respond to regional epidemics and vaccine-preventable diseases. The Department of Health (DoH) partnered with a strategic equity partner, the Biovac Consortium to create The Biovac Institute in 2003.
To be a Centre of Excellence rooted in Africa for the development and manufacture of affordable, high-quality vaccines to meet Africa and the developing world’s needs.
- To ensure that South Africa has the required domestic capacity to respond to local and regional needs for the provision of basic Extended Programme for Immunisation (EPI) vaccines
- To provide in the long-term capacity for the development and introduction of novel vaccines, focusing on the development of vaccines relevant to South Africa and Africa’s particular needs.
Since 2003, in excess of R200 million has been invested to build the infrastructure and expertise to support the organisation’s goal of becoming a fully-fledged vaccine manufacturer by 2013. Already the largest distributor of vaccines in South Africa, Biovac imports, labels, packages and distributes vaccines for both the South African public sector and Southern African Development (SADC) countries and plans to commence formulation and filling in 2013.
Developing a Centre of Excellence: Milestones
- 2012 Manufacturing Facility completed
- 2009 Research and Development Laboratories upgraded
- 2007 A new Quality Control Facility Officially Opened by Minister of Health
- 2005 A new Viewing, Labelling and Packaging Facility commissioned
- 2003 Department of Health (DoH) signs Public Private Partnership Agreement with The Biovac Consortium to create The Biovac Institute from State Vaccine Institute.
Based in Cape Town, South Africa, The Biovac Institute employs in excess of 130 permanent staff.